Delivery Order SPE2DR25D2205-SPE2DR26F1F79
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Imovax Rabies vaccine vials valued at $6,682.50. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 27, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $33,900.30 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials on June 5, 2025, with an ultimate completion date of June 6, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a $2,673.00 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The vaccine will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.74 on August 29, 2025, for the supply of IMOVAX Rabies Vaccine Vials. The contract is competitively awarded with no set-aside designation and employs firm fixed price terms, with an ultimate completion date of September 2, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,682.50 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine Vials, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, awarded on August 19, 2025, represents a non-competitive award under an existing contract vehicle. The vaccine will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials with a ceiling value of $10,023.75. This firm fixed-price delivery order, issued on September 26, 2025, is set to conclude by September 29, 2025, and will be fulfilled at the company's Conshohocken, Pennsylvania headquarters. The contract represents a competitive award with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical...
- The Defense Logistics Agency awarded a $10,023.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for IMOVAX Rabies Vaccine vials, with ultimate completion scheduled for September 3, 2025. This non-competitive delivery order represents a direct procurement of rabies vaccine supplies to support federal medical requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1F79Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Imovax Rabies Vaccine Vials at a firm fixed price of $25,113. This non-competitive delivery order is set to be completed by November 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military healthcare programs and the broader defense health system. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated significant capability in fulfilling competitively awarded, firm fixed-price delivery orders across diverse therapeutic domains and product categories to support military and federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 11/5/25 |